Achieving High 1H Nuclear Hyperpolarization Levels with Long...
Transcript of Achieving High 1H Nuclear Hyperpolarization Levels with Long...
This is a repository copy of Achieving High 1H Nuclear Hyperpolarization Levels with LongLifetimes in a Range of Tuberculosis Drug Scaffolds.
White Rose Research Online URL for this paper:https://eprints.whiterose.ac.uk/123750/
Version: Accepted Version
Article:
Norcott, Philip orcid.org/0000-0003-4082-2079, Rayner, Peter J. orcid.org/0000-0002-6577-4117, Green, Gary G.R. orcid.org/0000-0003-1977-7509 et al. (1 more author) (2017) Achieving High 1H Nuclear Hyperpolarization Levels with Long Lifetimes in a Range of Tuberculosis Drug Scaffolds. Chemistry : A European Journal. pp. 16990-16997. ISSN 1521-3765
https://doi.org/10.1002/chem.201703278
[email protected]://eprints.whiterose.ac.uk/
Reuse
Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of the full text version. This is indicated by the licence information on the White Rose Research Online record for the item.
Takedown
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request.
F
AL
P
Ab
pyra
is
me
im
tha
be
tre
the
lab
lab
tim
test
mo
of
va
re
im
stru
In
Tu
th
infe
201
st
ar
tre
fo
en
W
th
co
act
rifa
em
dr
up
re
[a]
FULL
AcLifet
Phili
bstr
yrazin
a di
metho
magin
hat th
e exp
reatm
he pa
belli
belli
mes
est co
motifs
a pyra
values
represe
mprove
ructu
ntro
uber
the W
infect
015
ruct
re u
eatm
form,
nzym
While
the p
comp
ctivity
ifamp
missi
rug d
ptak
eson
[a]
LL
chieet
ip N
tract:
zinam
isea
ods
ng (M
he fu
xpect
ment
arah
ing o
ing o
and
condi
s for
pyrazin
s of
sent
vem
ure.
rodu
rculo
World
ious
alo
ctures
used
tment.
pyra
me a
e its
prodr
plex
ity.[6]
The
picin
sion
distr
ke a
nance
Dr P
Centr
Depar
YO10
simon.du
Suppor
the do
ULL PAP
ievetime
Norco
t: De
mide
ase o
that
(MRI)
future
cted
t. Th
hydro
of k
of t
d po
ition
futu
zinam
f 14
ts a
ment
.
ductio
losis
rld H
s dis
lone.
s are
d in
nt.[4]
yrazino
and
s pre
rug
whic]
The 11
in in
ion tom
ribut
and
ce im
P No
ntre fo
partme
O10 5N
mon.du
pporti
docu
PAPER
vingme
orcott,
Despi
e and
of gro
at wi
RI) de
re pr
d to
This im
rogen
key s
he m
olarizat
ns to
ture d
mide
44.5
>7-
in p
ction
is (TB)
Healt
isea
.[1] Py
re d
n co
In t
inoic
d acc
recis
ison
hich
1C
in co
mog
ution
dis
imag
rcott
or Hy
ment o
NY, UK
ucke
ing in
umen
PER
vingmes
tt,[a]
ite
and eth
growin
ill d
etect
robin
sig
mpro
en ba
sites
mag
zatio
produce
detect
e an
5 s
-fold
polari
n
B) is
th O
ases,
Pyra
detail
conjun
the
c a
cum
se m
niazi
bind
radi
njun
ograph
n dat
istrib
ging
ott, Dr P
yperp
of Ch
UK
ett@y
nform
ent.
R
g Hin
[a] Pe
the
hamb
ng gl
drama
ctabil
ng of
significa
rovem
ased
s wit
gneti
on le
roduce
ction
analog
for
d ext
rizat
is a
Orga
s, kil
yrazina
iled
nctio
case
acid,
mulate
mode
zid is
ds to
iolab
nctio
phy
ta tha
ibutio
(MR
PJ R
perpolari
hemi
york.ac
mation
Higin a
ete
suc
mbuto
globa
matica
lity o
of the
cant
men
SAB
thin
izatio
evels
duce a p
on. Fo
gue l
5-H
extensio
tion
bact
ganiza
illing
namid
in F
tion w
se o
, is
lates
de of
is act
to th
beling
ion w
allo
that is
ion o
RI)
Rayner,
arisati
istry,
.ac.uk
on for
gha R
er J.
ccess
ol in
al con
cally
of nin
eir u
ly e
nt in
BRE
thei
ion t
ls of
proto
or exa
lead
H w
sion
leve
cteria
ation
g an
ide[2
Figur
with
of pyra
is pr
with
f the
activa
the ca
ng
with
ows
is use
of th
mig
ner, P
ation in
, Univ
.uk
r this
h 1HRange
J. R
ssful
n the
conce
imp
nete
uptake
enhan
det
E pro
ir m
transf
f the
ocol
xam
ds to
with
in
vel wh
ial in
on a
an est2] (1
ure
h etha
yrazi
rodu
hin
erape
vated
carr
of
sub
acc
sed
these
ight the
Prof. G
n Mag
versi
s artic
Hange
Rayn
ful us
e trea
ern.
prov
teen TB
ke a
ance
tecta
rotoc
molec
nsfer
ese
l to i
mple,
to a s
up
relax
when
infec
as o
stima
1) a
1, a
tham
zina
uced
Myc
peut
d by
rrier
pyra
bseq
cess
in T
se t
there
GGR
Magnet
ity of
cle is
Nuange
ner,
se
atme
We
ve th
TB re
and
e th
ability
col in
cular
r cata
age
iden
, deu
struc
to
axatio
com
ction
one
imated
and
are t
mbut
amid
d b
coba
tic a
y Ka
prot
razina
que
s to
TB d
thera
refore
GR Gre
tic Re
f Yor
s give
Nucnge o
r, [a]
of i
ent o
illust
he
releva
distri
heir
ty is
n con
r stru
talys
ents
ntify st
uterat
ctura
20%
on t
mpared
n tha
of th
d 1.
ison
two
tol
e, th
y th
bacte
actio
atG
tein
nam
ent im
to ph
diagno
rape
fore a
reen,
esonanc
ork
en vi
cleof T[a] Ga
ison
of tu
strate
mag
vant
ribut
effica
s ach
njun
ructu
yst. T
are
struct
ration
al form
% p
time
red t
that is
the
.8 m
niazi
first
or r
the
the
erium
ion re
cata
Inh
amide,
imag
harm
nosi
apeutic
aid in
Prof
onance
ia a l
learTu
ary
niazid
ubercu
e he
gneti
t agen
tion
cacy
chieve
nction
ures,
The
quan
ctura
n of t
rm th
polari
and
to its
is rec
mos
millio
zid[3]
first-lin
rifam
propo
pyrazi
m tu
rema
talase
hA to
, iso
ging
maco
sis. [7]
tics b
in T
SB D
e
link at
ar Hube
y G.
zid, ri
rculo
here a
ic re
ents
in vivo
cy in
ved
n wi
s, an
T1
antif
rally
the 6
hat e
rizat
d al
s un
ecog
st si
on p] (2
ne d
mpic
opose
yrazin
tuber
ains
se to
to red
sonia
g by
okin] Im
by
TB tr
Duck
at the
HyperTuberc
. R.
rifam
osis
a se
reso
ts and
vivo
n di
by u
with th
nd th
rela
fied
opti
6-po
exhib
rization.
lmos
nopti
gnize
signif
peop
2), w
drugs
icin
ed a
inam
rculo
s un
to fo
redu
iazid
y po
inetic
magin
mag
reat
kett
e end
yperrcul
R. G
mpic
(TB)
eries
onanc
d no
wou
iseas
use
the2
the2
axatio
und
timize
ositio
bits
. Th
st 1
imize
ed b
ifica
ple
whos
gs th
in
activ
midas
osis
nclea
orm
uce
d an
ositro
ic an
ng th
gnet
tmen
d of
perpulo
Green,
cin,
) it
of
nce
ote
uld
ase
of
H-
H-
tion
der
ed
tion
T1
his
10x
ed
by
ant
in
se
hat
its
ive
se
.[5]
ar,
a
its
nd
ron
nd
he
etic
nt.
rpollos
en,
H
sp
re
th
in
1
a
d
H
sp
o
F
(2
S
E
tri
A
w
T
fe
in
u
sp
th
re
si
(S
h
th
polalosis
[a] a
Howe
spect
esea
that m
inform
1.5 T
asso
deriv
Hyper
spin
of ma
Figure
2).
Schem
Exchang
trimethy
A nu
which
Those
feedst
induce
unde
spin
throu
esulti
signa
SAB
hyper
throu
ariis Dr
and
ever
ctros
arch
mea
mati
T m
ociate
ived p
erpo
state
agnitu
re 1.
eme
hange
ethylpheny
umber
h ar
se th
stoc
ced
etect
mo
ough a
lting
als.[12
BRE)
erpola
ough th
rizaDru
d S
r,
oscop
h and
eans
ation.[
magn
ated
posi
polariz
ate po
itude
Struc
1.
(SA
heny
er o
are beg
that
ock ar
po
ctable
omen
a ch
ng envi12]
RE) is
lariz
the
izationDrug
Simon
wh
py a
nd m
they[8] This
netic
nuc
sitive
ization
popu
e.[9]
ucture
Rep
ABRE
yl)imi
of h
begin
ut
re k
olariz
le by
ntum
hem
nviro
Sign
s a
izing
cata
tiong Sc
on
hile
and
medic
ey ca
This
c fie
clear
ely f
ion t
ulation
es of
prese
E) p
midazo
hype
nnin
ilize
know
rization
y NM
m, w
mical
onme
gnal
rap
ma
alytic
onSc
B.
nu
MR
icine
cannot
cha
ld o
r sp
from
tech
tions
of the
ntation
proce
ol-2-y
erpola
ng to
ze par
own co
tion)
MR
when
l reac
ents
A
apidly
ateria
tic tra
Lecaf
Du
nucle
RI ar
e the
ot ro
alleng
of a
spin in
om just
chniqu
to im
tuber
on of
ess for
ylidene
lariz
to find
arah
colle
pro
spe
hen it
actio
s can
Ampli
ly em
ials th
ansf
eveaffo
ucke
ear
re in
they s
outin
nge st
com
inte
st 1
ues
impr
tuberculo
of t
for s
dene.
izatio
d use
hydr
ective
ocess
ectro
is in
tion th
n pr
lifica
mergi
that
sfer o
velolds
ett*
m
nvalu
suffe
tinely
stem
mmo
ract
in 10
cha
prove
ulosis
he
substra
tion m
se in
rogen
e by
sses.
osco
inco
that b
produ
ation
ging
use
of po
lslds
*[a]
magn
luabl
ffer fr
ly pro
ms fr
only
ction
105 o
ange
e detec
drugs
Sign
trate
meth
in the
en (
y the
s. [11
copy
corpor
break
uce st
n B
g and
ses p-
olari
ws
netic
ble a
rom
rovide
rom
ly use
pro
of th
e the
etect
gs py
nal A
L wh
hods
he st
(p-H
he te1] Al
as
orate
aks i
stro
By
nd ine
-H2.
rizat
with
ic
anal
an
ide ac
m the
sed h
oduc
he p
he as
tabil
yrazi
Amp
wher
s ha
tudy
H2)
erm
Altho
it po
ed int
its n
rongly
Re
inex
.[13] I
tion
th L
reso
ytica
inhe
ccess
e fact
hosp
ces
roton
ssoci
ity b
nami
plificati
here IM
have
of li
as
PHIP
ough
osse
into
nucle
ly hyp
eversi
xpen
It ach
from
Lo
sonan
al te
heren
ss to
ct tha
spital
a si
ton nu
ciated
by se
mide (
ation
IMes i
bee
livin
the
IP (pa
gh p
esse
a n
ear sy
yperpo
sible
ensive
chiev
m p-
on
ance
techn
nt in
to th
at e
l sca
signa
nucle
ted B
seve
(1) and
by
is 1,3
been de
ng sy
e po
para
p-H2
es no
new
sym
erpola
e E
ve m
ves
-H2 to
ng
(
niques
insen
his ty
even
anne
nal tha
ei pr
Boltz
eral or
and is
Rev
1,3 -bi
deve
syste
polariz
ahyd
is
no an
mo
mmetr
larize
Exc
method
this
to a
(NM
ues fo
nsitiv
type
n in th
ner th
that
rese
ltzma
orde
soniaz
eversi
bis(2,4,6
elop
ems.
izatio
ydroge
its
angu
olecu
try th
ed M
xchang
od fo
is resu
a targe
MR)
for
ivity
e of
the
the
is
ent.
ann
ers
azid
sible
4,6-
ped
.[10]
ion
gen
self
ular
ule
the
MR
nge
for
sult
rget
F
su
m
app
IM
COD
ta
tra
th
su
fre
ove
hyp
oth
hyp
hyp
fo
ub
de
m
sc
ha
nu
iso
SA
sta
fu
rep
fu
de
re
pha
th
of
im
m
po
ta
app
m
R
SA
py
pyra
pyra
nu
be
of
re
T1
FULL
subst
mater
ppro
IMes
OD
target
ansf
the ir
subst
equenc
ver
yper
thers.
yper
yper
form.[
biqu
etect
methods
scientif
as in
ucle
otop
ABR
ates
functio
eport
furthe
etect
elaxa
harm
through
f th
impro
molecu
olariz
target
ppro
might
Res
ABR
yrazi
yrazi
yrazi
ume
eing
f 80
espe
1 va
LL
rate
rial’s
A co
oach
=
=
t (L
sfer th
iridiu
rate
ency
the
erpola
s.[17]
A
erpola
erpola[18] T
uity
ction
ods
tifica
involv
ei a
pica
RE p
s h
iona
Both
ted
ther o
ction
ation
mace
gh se
these
ove.[
cule
izati
t cou
oach
t resu
sults
BRE
zine
zinam
zine-
erous
g activ
In m
0.6, 2
ectiv
lues
ULL PAP
e (L
’s ch
comm
h is f
1,
cis,
L), a
then
ium
e at
y ex
las
lariza]
ke
ariza
larize
This
and
n hig
to h
ally
lved
appro
ally
pola
have
alize
Both p
to
optim
n. H
ion
eutic
selec
e su[20, 2
e of
ion
uld
h lies
sult.
ults and
inve
e-2-c
mide
-2-ca
us o
tive
meth
20.9
ively.
s of
PAPER
(L) v
hemic
mon
form
,3-bis
cis-
and
n rea
cata
low
xcita
last fe
ation
ey
ation
ed n
is tim
d high
ghly
hype
cha
d a ra
oach
labe
ariza
e b
ed py
pyra
pa
imiza
Here
time
icals
lective
ubst23] This
p-H
and
be b
es in
and
nvestigat
carboxy
e-clas
arbo
other
aga
hano
9 an
. In c
64,
PER
via
ical
n pol
med
is(2,4
1,5-
p-
eadily
talyst
w fie
ation
few ye
n o
lim
n te
nucl
mesc
gh
desi
erpo
allen
ange
hing
elled
ation
been
pyrida
azinam
particip
ation
ein
es
s, a
e deu
trate
This
H2 p
and co
bene
n the
d Di
estigat
boxy
lass
oxyla
r est
ainst
nol-d
and 21
contr
23.4
R
an
iden
olariz
by
,4,6
-cycl
H2
y occ
st fro
field,
n at
year
of 1
mitatio
tech
clei r
scale
natu
sirab
polariz
enging
ge of
g 2
d m
n of
n u
azine
amid
ipate
n is
we
of
and
eute
tes, th
hyp
posse
conse
efici
e sim
isc
tion
ylate
su
late
ster
st seve
d4 so
21.2
trast
.4 and
irid
entity.
izatio
the
-trim
clooct
(Sch
ccurs
om
alth
t hig
ars h
H,
tion
hniq
relax
is o
ural
able
ize n
ng bu
of app
min
meth
f up
used
ne w
ide
e in
need
de
f th
so
teratio
their
pothe
sess
equen
ial. C
mpli
cus
n o
e (3)
substr
(3
der
vera
solutio
.2 seco
st, th
nd 23
idium
y.
tion ca
reac
imeth
ctad
chem
s thr
the
lthoug
igh fie
have15N,
th
ues
x ba
often
abu
in M
nuc
but ve
proa
inute
thyl
p to
d to
with a
and
in S
eded
evelo
these
some
tion.
ir su
thesis
sses
ently
Cons
lified
ssio
of p
3) W
rates
, T
erivati
al str
tion,
cond
the m
23.5
m co
cataly
eactio
thylphen
adiene
me
roug
e hyd
ugh it
field
ve see
N, 31
that
s is
back
n ele
bund
MRI.
uclei,
very
oache
utes
nic
50%
to
a TLLS
d is
SAB
ed pr
op
se
e re
By e
uitab
s st
a sp
y tra
nseq
d an
on
pyra
We
s p
Table
tives,
rains
1 wa
ds fo
methyl
.5 seco
omp
alyst
ion of
lphen
e),
1).[1
gh th
ydrid
it ca
ield.[16]
een1P
is
is t
to
levat
danc
I. He
in a
imp
es.[1
hav
icotina
%.[2
sto
LLS v
isoniaz
ABRE
prior
a s
ke
relate
exte
ability
tems
spec
ransfe
quen
nd st
pyrazina
beg
pyraz
e 1
s, h
ins of
was
for p
hyl e
cond
plex
tha
f [IrC
nyl)im
with14]
he J
de li
an a
De
sign
and
is a
he
their
ted f
ce o
ence
a lon
port19] T
ve
inate20] A
ore
value
iazid
hy
to
strat
ey
ed
endin
y to
s fro
cific
er t
ntly,
stron
nami
gin o
zina
1).
have
f M.
foun
prot
ester
ds.
with
at is
[IrCl(CO
imidaz
ith the
Rev
J-co
ligand
also
evelop
nifica
nd 13C
asso
rat
ir the
for he
of 1
ce the
ng-l
tant
T1 rela
been
in
Alterna
ma
e of
d ha
yperpo
their
tegy
tub
struc
ing th
to S
om
am
to few
a fu
nger
amide
our
amid
The
ve bee
tuber
und t
tons
r 3 w
NMR
thou
use
COD
azol
the h
versi
coupli
ands
be
opm
cant
C nu
ociate
te
therm
hete
H n
he e
lived
rese
laxa
en r
in co
nativ
agne
ove
ave
pola
ir p
y to
bercu
uctu
the r
SABR
the
moun
ewer
further
MR
(1)
stud
de (
he la
been
ercu
to ex
s 3-H
was
R sa
ut ch
sed in
D)(IM
-2-yl
hyper
sible
ling n
into
driv
ments
prog
nucl
ated
at
mally
teronuc
nucl
establ
d for
search
xation
reporte
conju
tively
etiza
er 4
alr
lariza
poten
to in
culosi
tural
relax
RE
e fact
unt of
er 1H
er bene
R re
) a
dy w
(1)
latter
rec
culosi
exhib
H, 5
fou
sampl
chan
n the
IMes)]
yliden
erpo
po
netw
to th
ven
ts in
ogress
clei
wi
wh
y dis
nucle
clei m
ablish
rm,
ch g
n tim
ported
junctio
ly, 1H
zation
min
read
ation
tential
increa
sis
ana
xatio
cou
ct th
of und
H site
enefit
espon
and
with
and
r, a
cogn
sis.[24
ibit T
5-H
und to
ples
nging
e SAB
s)] (w
ene,
olariz
olariz
work
he t
by
in SA
ess in
amo
with
hich
istrib
lei bu
mak
hme
refle
goal
imes
rted in
ion
H sin
ion in
nutes
dy
ion,[22]
ial in
rease
re
nalog
ion t
uld
hat
nderly
ites
efit to
onse
me
h the
d m
along
nize4]
T1 va
and
to ex
of t
g th
ABR
(whe
an
rization
izatio
rk[15]
targ
rad
SABR
in th
ongs
a
th
ribute
ut th
ke it
ent o
lect
l tha
of 1
in a
wit
inglet
in
s.[21]
bee] bu
viv
e th
relate
gues
time
als
eac
rlyin
on
o this
e tha
ethy
e tw
methy
gside
ed a
alue
d 6-
xhib
thes
he
BRE
ere
nd
ion
ion
of
rget
dio
BRE
he
st
all
he
ed
he
its
of
a
at
H
an
ith
let
a]
en
ut
ivo
he
ed
s,
es
lso
ch
ing
a
his
at
yl
wo
hyl
ide
as
es
H
bit
se
tw
ra
sa
p
sh
a
im
a
m
le
w
h
Tab
deuter
Com
1
3
4
5
6
7
8
9
3
4
5
6
two ag
atio
samp
polar
shaki
asso
imme
avera
measu
levels
were
highly
able
deuter
ompound
agen
with
ples
rizati
king
ociate
edia
age
sure
ls of
e 2.4
ly su
1.
deuterated
pound
ents w
th th
s we
ation
the
ated
ate1H
emen
f 1.7
4%,
suitab
T1 v
d methy
pound
wer
the
ere p
tra
e sam
wit
tran
H NM
ents,
7%,
4.3
ble f
value
thyl p
re pr
pre
place
ansfe
mple
h a
nsfe
MR
, un
, 2.6
3% a
for SA
es an
pyraz
repared
ecata
ced u
er ex
le for
a 9
r in
sign
nder
.6% a
and
SAB
and hy
razinec
Si
356
356
56
36
35
5
6
35
356
56
36
35
pared
alyst
under
expe
for 10
9.4
into
gnal i
er SA
and
3.9%
BRE.
hyper
necarbo
ite
-H:-H:-H:
-H:-H:-H:
-H:-H:
-H:-H:
-H:-H:
-H:
-H:
-H:-H:
-H:-H:-H:
-H:-H:
-H:-H:
-H:-H:
pared at
st [I
er 3
erim
0 se
T N
the
inten
ABRE,
nd 2.7%
%. H
. As
perpolari
arboxylat
T
Methanol
Ethanol
a co
IrCl(
bar
iments
secon
NMR
ma
tensitie
RE,
.7%
Hen
s exp
arizat
ate deri
T1(no ca
ethanol
80.620.921.2
64.123.423.5
24.924.0
91.184.0
99.7144.5
39.5
98.1
53.053.1
thanol
55.417.217.2
11.011.7
18.320.9
21.423.8
conce
l(COD
r of p
ts u
nds
R sp
agne
ties
corr
resp
ence,
xpect
ation
derivati
cat.) (s)
ethanol-d4
80.620.921.2
64.123.423.5
24.924.0
91.184.0
99.7144.5
39.5
98.1
53.053.1
thanol-d6
55.417.217.2
11.011.7
18.320.9
21.423.8
centra
OD)(I
p-H2
unde
in t
spec
net
see
rresp
pect
bot
ted,
leve
atives
)
4
ration
IMe
2 an
ertak
he 6
ctro
for
en fo
pond
tively
th of
, the
els o
s.
T1(w
tion of
s)]
nd a
ken
65 g
mete
me
for 1
onded
ly, w
f the
e me
of 1,
with cat.
32.712.112.3
20.69.3
12.0
10.314.1
26.039.2
32.926.2
22.6
43.1
25.621.8
8.34.67.4
5.47.6
5.913.6
10.811.5
f 20
(5
serie
wh
gauss
ter,
easu
1 in
to
while
ese
easu
3 a
t.) (s)
32.712.112.3
20.69.3
12.0
10.314.1
26.039.2
32.926.2
22.6
43.1
25.621.8
8.34.67.4
5.47.6
5.913.6
10.811.5
0 mM
mM
ies o
which
ss fr
foll
surem
the
po
e th
mate
ured
and
) P
Lev
M in
M). T
of S
h invo
fringe
llowed
ment.
e resu
olariz
those
teria
d T1 v
a ser
Polari
Level
2.72.81.6
4.33.92.4
3.52.8
6.76.2
11.99.2
7.8
2.5
8.87.5
3.161.960.95
2.350.99
4.43.9
4.72.9
in a 4
The
SABR
volve
e fie
ed
t. T
sulti
izatio
se for
als a
valu
eries
arizati
el (%)
2.7 ± 0.2.8 ± 0.1.6 ± 0.
4.3 ± 0.3.9 ± 0.2.4 ± 0.
3.5 ± 0.2.8 ± 0.
6.7 ± 0.6.2 ± 0.
11.9 ± 09.2 ± 0.
7.8 ± 0.
2.5 ± 0.
8.8 ± 0.7.5 ± 0.
16 ± 0.1.96 ± 0.0.95 ± 0.
35 ± 0.0.99 ± 0.
4.4 ± 0.3.9 ± 0.
4.7 ± 0.2.9 ± 0.
4:1
These
RE
ved
ield
by
The
ing
ion
r 3
are
ues
s of
tion
%)
.3
.3
.1
.3
.2
.2
.3
.2
.3
.3
0.6.5
.2
.2
.3
.2
.08
.05
.04
.05
.02
.2
.3
.3
.2
F
of
in
fro
fa
th
be
st
Sy
m
hyp
and
co
tra
sy
th
Sch
isotopcM
Na
S
py
po
a
deu
re
wh
In
exh
leve
su
25
its
ca
co
st
po
~3
va
hen
FULL
f 3 u
in acc
om th
fall in
that fo
etter
ronger
ynth
methy
yper
nd 3
corresp
anse
synth
the su
chem
otopol
Methy
a2CO
SABR
yrazi
olariz
sing
eute
elaxa
hilst
In con
xhib
levels
subst
5 an
its ab
cataly
conse
rikin
ositio
3700
value
ence
LL
under
ccord
the
in T1 fo
for 3
tter po
ger
hesis
hyl p
erpola
3 we
spond
seste
thetic
supple
eme 2
ologues
ethyl 3,6
O3 us
BRE
zine
izati
ngle
teratio
ation
st de
ntra
ibits si
ls (6
rate
and 3
bsen
lyst
sequen
ing re
tion
00-fo
es of
ce we
ULL PAP
er SA
danc
free
for t
3 wa
olariz
inte
is of
pyra
lariza
ere p
ndin
erific
pro
lemen
2. S
ues
6-dib
sed in
studi
e-2-c
ion d2H-
ion
ion tim
eliveri
ast,
sign
6.2‒6.7%). In this case the effective e in
39 se
nce.
is t
ently
resu
as
old s
f the
e ha
PAPER
SAB
ce w
e an
the s
as 6
rization
eract
of de
razine
ation
prep
ing h
ication
roced
enta
Synth
3-12
bromo
n plac
tudie
carboxy
data
-labe
at t
imes
ring
com
ignifica
‒6.7%). In this case the effective the
econ
The
there
ly high
ult th
com
signa
e 1H
ave
PER
RE
with the
and bo
sites
60%
tion tr
tion
eute
ne-2-
n le
epared
heter
tion o
dure
ary in
nthetic
2.aC
opyra
ce of
ies
boxy
a for
el a
the
es of
com
mpou
cantly
‒6.7%). In this case the effective pre
nds,
hese
erefor
igher
though
mpou
gnal ga
H nucl
ach
R
con
the fa
bound
s in
% wh
trans
with
erat
-carb
level,
ed by
teroaryl
or a
es an
infor
c route
Comm
razine
of K2C
on
ylate
r the
are
3-p
the
mpa
ound
tly im
‒6.7%). In this case the effective esenc
s, and
num
fore r
r hy
ugh w
ound
gain)
uclei
chieve
ndition
fact
d fo
1 und
which
ansfer
th the
ted a
arboxy
, a se
by the
oaryl ch
amid
and ch
formatio
oute
merc
ne-2-c
CO3.
n d
e
he me
deta
positio
e re
parab
5,
improve
‒6.7%). In this case the effective nce
nd th
umber
redu
perpo
was
6
) and
in 6
ed ou
ons
ct tha
forms.
under
is co
r in
e ca
ana
xylat
serie
e pal
chlo
idatio
char
tion.
to
ercially
carbox
deut
(3)
ethyl
ailed
tion
emai
ble le
whe
ved
‒6.7%). In this case the effective of the
they in
ers in
uced
pola
ach
gav
nd 9
6 ar
our
at 2
at the
s. [23,
er the
consi
3 a
cataly
alog
late (
ies o
allad
loride
tion a
aracte
n.
the
avai
rboxylate
tera
Th
yl est
ed in
, ga
ainin
levels
where
rela
‒6.7%). In this case the effective the
increa
indic
d by
lariza
hieve
ave 1
9.2%
re now
initi
298
hey re, 25] The
hese
siste
as th
lyst.
ogues
(3)
of d
dium
es u
as s
eriza
pyr
ailabl
ate us
ated
The
ster d
in Ta
ave
ining 1
ls of
the
laxat
‒6.7%). In this case the effective hyp
reas
icate
by s
ation
ieved
11.9%
% po
ow
ial g
K w
refle
The
e con
ent
hese
s of
In o
deut
ium-ca
unde
show
ation
razine
le.b
used
analo
relax
deriv
able
a
H n
f SAB
lab
tion
‒6.7%). In this case the effective perpo
se to
e tha
subs
ion lev
with
% p
olariz
100
goal
were
flect a
cor
nditi
with
se diff
pyra
orde
terat
cataly
der D
wn
n da
ne carbo
D2O/
as the
nalo
laxa
ivativ
e 1.
sligh
nucle
ABR
bel is
tim
‒6.7%). In this case the effective olariz
to 91
at re
strate
vels
ith deu
polar
izatio
00 and
of p
e fou
a we
rresp
itions
ith the
iffere
yrazi
der to
ted
lysed
D2,[20
in S
ata a
arbox
/THF
the starti
logue
ation
tives
Su
ht in
ei co
RE p
s in
times a
‒6.7%). In this case the effective T
izati
1 and
elaxa
e d
resu
deute
ariza
tion fo
nd 145
produ
und
eight
spond
s wa
e obs
ence
zinamid
to imp
deri
d reduc20, 26]
Sch
are
xylat
F ins
tarting
ues
n a
4-6
ubstr
incre
com
polar
in the
and
T1 va
ation
d 84
xatio
deute
sult. [
ratio
ation
for 5
45 se
duci
nd to d
ted r
nding
was 47
bser
ces su
amide
prove
rivativ
ductio
foll
cheme
pre
ate and
nstead
ng m
of
and
6 tha
rate
ease
mpared
rizatio
e 5-
pola
value
cata
84 seco
tion w
eratio20] T
tion a
n for
5-H
seco
cing
dec
resp
g av
7%,
rvat
sugg
de (1
ve o
tives
tion
llowe
e 2
esen
and
d of
mater
m
SA
at co
e 4,
e in
red
tion
-pos
lariz
es o
alys
econ
within
tion
The
at th
r 3-
H. Th
onds
a st
creas
pons
verag
, wh
ion
gest
(1) and
on th
s of
of th
ed b
2. Full
nted
ami
EtOD
rial a
methyl
SABR
onta
wit
n th
to 3
to it
sition
rizatio
of th
st ar
nds in
n th
an
mos
he 6
-H (
The T
s an
tron
se
se
ge
hile
of
t a
nd
he
1
he
by
Full
in
mide
OD.
and
thyl
BRE
ain
ith
he
3,
it.
ion,
ion
he
re
in
he
nd
st
6-
(a
T1
nd
ng
a
co
p
w
d
th
co
n
S
2
sh
S
re
co5J
th
p
rep
a
e
a
ch
vi
S
d
In
ca
se
N
5
o
in
in
re
a
n
o
p
te
d
rea
in
co
Tab
sol
Com
5
6
and
consi
prese
which
desir
that
comp
not a
SABR
2.5%
shorter
Sche
emo
coup
JH-H
the C
predic
epla
amen
enhan
althoug
change
visco
SABR
deute
In orde
cataly
serie
NHC
5 an
optim
increa
inform
espo
at 9.4
not a
obse
polar
temp
d22-IM
ealize
inform
condu
able
olution.
ompound
long
siste
sent w
Fro
h co
rable
wou
poun
a lon
RE
% po
ter. T
eme
ote to
pling
cou
We
CH3
ictio
lacing
enable
ance
ough
nge
osity
BRE
erat
rder
lyst
ies of
HC iso
and 6
timal
creasin
mati
onse
.4 T.
as effi
served
rizati
peratu
IMes
zed
mati
ducte
2. E
on.
pound
ng live
nt w
with
om
conta
e pr
ould
ounds
ng a
resp
polariz
The
1)
to e
ng in
uplin
e so
gro
tions,
ng th
le
emen
h the
is co
y and
inv
ted
to se
can
f de
otopo
6, w
with
ng a
ation)
e of
. The
ffica
d p
ation
ture
es ca
(co
ation)
ed ha
Effect
pound
ved
with
hin 3
an
ain
robe
be
exh
as t
pon
ization
These re
occ
ester
the
ng th
ough
oup
this
he m
solv
ents
e be
cons
d he
nvestiga
analo
see
n be
eute
olog
when
h bo
as
). Th
f 6 c
The ca
aciou
pola
tra
e. This
ataly
orres
). Th
has
t of a
resp
the
3.
MR
a s
es d
see
hibit
thos
nse o
ion a
resu
curs
r, w
e SAB
hat w
ht to
in 6
is d3-
meth
vent
ach
est re
siste
ence
tigation
nalogu
if th
e red
erate
gues
n th
oth
deta
he p
corre
ataly
ious, s
arizat
ransf
This
lyst a
spon
he te
be
a de
spons
e rem
RI per
single
ue to
en
ited h
se o
of 7
achie
sults co
pre
with
ABR
woul
to fu
6 wit
-meth
thano
t eth
chieve
resu
tent
ce mo
tions
gues
the e
educe
ted a
s had
the c
the
tailed
polar
espon
lyst b
sligh
tion
sfer
reve
at 0°
nding
emp
en
deutera
Li
d
d
se.
emova
ersp
le p
to th
in a
highe
of 6.
7.8%
ieved
confirm
edom
the
RE ca
uld b
furthe
ith a
ethyl
anol-d
ethano
ed a
sults w
with
ore fa
ns ha
s of
effect
ced,
analo
had the
cataly
the T1
ed in
ariza
onds
bear
htly
n. In
effi
veale
°C a
ng to
pera
sho
terated
Ligand
IMes
d22-IM
IMes
d22-IM
This
val o
spectiv
proto
the red
an
her p
. Ho
% po
ved for
nfirm
mina
ass
cataly
be use
ther im
a CD
yl est
d4 s
nol-d
across
were
ith the
facile
arnes
f m
ct of
this
logue
the for
lyst
1 va
in Tab
ation
s to
ring
incre
In a
fficien
ed th
a ~63
to 20.4
ature
own
catal
gand
es
IMes
es
IMes
is in
of th
tive,
on,
educt
ech
proto
oweve
olariz
or 8
firm the
ately
ssocia
lyst
sed
mpro
CD3 g
ster pe
solve
d6,
cross
e stil
the a
le re
essin
methy
f rela
is pro
ues o
form sh
bea
values
able
n leve
to a ~
the
creasi
an e
ncy,
that w
6300
0.4%
e at
to
atalyst
S
36
36
35
35
increa
the st
, su
and
ction
cho p
ton
ver,
izatio
eve
erefo
ly at
ciated
bein
for
ove
roup
perfor
ent
the
this
ill ach
assoc
elaxa
ing
hyl p
laxa
ocess
of [I
show
ears
s and
le 2
vel of
~4200
e d24
sing
effor
, w
whe
00-fo
% p
whi
sign
and
Site
3-H:6-H:
3-H:6-H:
3-H:5-H:
3-H:5-H:
ase
stron
ubstra
d tw
ion in
plan
T1 v
r, 7 p
ion w
en t
ore t
t the
d 4J
ing
8.
the
p to
rform
with
e T
is se
achiev
ociated
xation
deut
pyra
ation
ss w
IrCl(
own
a d
nd
2 (a
of 1
00-f
4-IM
T1 v
rt t
we
en 6
old s
polariz
hich
ignific
d sub
in
ng 3
rate
wo 2
in che
nar
valu
prod
whic
thou
that
e nit
JH-H
mo
ese
o pro
med
h th
T1
eries
ieved
iated
ion th
utera
razine
n ca
was
l(COD
in Fi
d22-I
hyp
also
13.4
fold
Mes li
value
to f
tes
6 wa
sign
rizat
the
icantly
bstrat
T1(wit
(s)
2639
4054
3226
3731
T1 r3JH-H
s su2H la
emic
image
lues th
oduce
ich is
ough
sub
itrogen
pola
re e
resu
oduce
wor
the m
valu
s of
d with
increa
that re
rated
ne-2-
used
re-
OD)(IM
Figur
IMes
perpo
see
% se
signa
ligan
lues,
furth
tested
was p
nal g
tion,
SA
tly a
te sy
th cat.
26.039.2
40.854.0
32.926.2
37.931.3
relax
H co
such
labe
ical sh
ge.
than
ced a
is hig
its
bstra
en ce
lariza
effici
sults
ce 9
rse tha
more
lues
com
ith 6
crease
esu
d ca
-carb
sed by
-exa
IMes)]
ure 2
s liga
polariz
e su
seen
nal enh
and, ho
but
ther
th
polar
gain
, se
ABRE
affect
ystem
t.)
xatio
coupli
as
bels,
shift
Wh
an 1 th
an im
igher
T1 va
ate b
centr
atio
cient
by
9. De
than
e b
and
mpou
6 (4.7
se in
sults.[27
cataly
arboxy
y the
xamine
s)] w
. Re
gand
izatio
suppl
n fo
enh
howe
with
imp
the
rized
n for
see su
E ca
ct th
tem in m
Polari
Level
6.76.2
10.99.0
11.99.2
13.49.5
tion tim
ling th
7
wou
ift arte
hile
they
impre
r tha
value
bind
tre th
tion tr
tha
rep
Despit
n 6.
biolo
nd
ound
.7%)
in so27]
alysts
xylat
the SA
ned
wher
esults
nd, p
tion
pplemen
or the
enhance
weve
ith a lo
prove
effe
d wi
r H-
suppo
cataly
the r
methano
arizati
el (%
6.7 ±6.2 ±
10.9 ±9.0 ±
11.9 ±9.2 ±
13.4 ±9.5 ±
time
that
and
uld
tefac
the
y we
ress
than th
es a
ding
that
trans
an the
placi
spite o
Up
logica
signa
nds fe
). T
solve
s wit
late
SABR
with
ere th
lts w
prove
leve
mentar
the 3
ceme
ver, w
loss
ve th
ect
ith th
-3 w
porti
lysis
rate
ethanol
ation
(%)
± 0.3± 0.3
± 0.5± 0.5
± 0.6± 0.5
± 0.7± 0.3
e is
t is
d 8
be
acts
ese
ere
sive
the
are
g (L,
t is
sfer
the
ing
our
pon
ally
ignal
ell,
This
ent
with
(3)
RE
h a
the
with
ved
els
ary
3-H
ent
was
s in
the
of
the
was
rting
is is
of
ol-d4
5
6
7
,
F
dis
of
te
tra
Tab
deri
Com
1
10
11
12
13
14
1
10
11
12
13
14
*[Ir
FULL
issoci
f th
temper
ansf
able
derivati
ompound
10
11
12
13
14
10
11
12
13
14
*[IrCl(C
LL
ciatio
the
eratu
sfer to
3. T
tives
pound
(COD)(
ULL PAP
iation
SAB
ures
o 6.
T1 va
d
OD)(d22
PAPER
of th
ABRE
s, w
.
alues
-Ime
PER
the su
E a
which
s and
S
es)] u
R
subst
activ
h pr
and hyperp
Site
3-H:5-H:6-H:
5-H:6-H:
3-H:6-H:
3-H:5-H:
6-H:
5-H:
3-H:5-H:6-H:
5-H:6-H:
3-H:6-H:
3-H:5-H:
6-H:
5-H:
used
strate
tive co
prove
perpol
T
ca
as th
te m
com
ves to
olariz
T1(no
cat.) (s
Methanol
80.620.921.2
19.420.4
34.833.8
51.251.5
102.
55.9
Ethanol
56.513.613.8
13.413.1
25.630.3
32.834.9
57.4
29.0
the ca
mole
mplex
o be
zation
(s)
ethanol
692
44
88
25
2.8
9
thanol
568
41
63
89
4
0
atalys
lecule
lex w
e mo
on lev
T1(w
ol-d4
39
39
24
l-d6
1818
15
st
e.[14
will
ore
vels
with cat
32.712.112.3
11.311.6
21.612.7
.4 (49
.3 (49
39.8
.5 (37
18.38.08.7
6.96.8
8.34.1
.4 (26
.8 (26
12.0
.3 (16
14b] A
be
effici
of de
t.) (s)
713
36
67
9.6)*
9.1)*
8
7.0)*
307
98
31
6.1)*6.6)*
0
6.9)*
As su
e lo
cient
deuter
such
longer
t for
uterated
Pol
Lev
2.72.4
4.1 ±
4.5 ±3.3 ±
6.1 ±
h, th
er a
for po
ed pyraz
olariz
Level
2.72.81.6
3.22.1
3.42.8 ±
7 (3.924 (3.92
0.9
± 0.3
2.62.01.2
1.7 ±1.1
3.02.2
± 0.3± 0.2
2.2
± 0.3
he lif
at
olariz
razin
zatio
(%)
± 0.3± 0.3± 0.1
± 0.21 ± 0.1
± 0.1± 0.0
92 ± 092 ± 0
± 0.1
(9.3
± 0.2± 0.2± 0.1
± 0.01 ± 0.1
± 0.2± 0.1
(7.7(6.4
± 0.1
(7.6
fetim
low
rization
namid
on
331
21
102
0.04)*0.04)*
1
± 0.6
221
081
21
± 0.4± 0.4
1
± 0.2
me
wer
ion
de
**
6)*
4)*4)*
2)*
F
S
(1
la
d
a
yi
w
d
p
th
S
s
p
ca
h
si
A
co
O
2
is
w
p
p
b
u
h
b
o
u
n
w
2
se
th
u
a
re
re
co
le
im
le
im
w
su
o
va
Figure
SABR
1) In
labell
detail
again
yieldin
with its
d22-IM
prese
the su
Syste
subst
polar
can
has a
single
Additi
conse
Optim
2- and
isolated
whilst
polar
previ
by est
under
hydra
be c
ortho
unlabe
numb
when
2 an
seco
the si
upon
are in
esult
elax
comp
level
impro
level
impro
with
sugge
occu
varyin
re 2.
BRE
Inves
lled
iled
in affe
ing
its tw
IMes
sence
subs
ema
strat
rizati
also
a di
le n
itiona
sequ
timal,
nd 5
ted
st m
rizati
vious
ster
er D
azin
conv
thoace
The
belle
ber
n co
and 1
conds
signa
n de
incre
lt in
xatio
pare
is
oved
for
oved
the
gest
urs a
ing
Deuter
stu
estiga
deriv
in T
fecte
imp
two p
es ca
e of
bstrate
atic
tes
ation
o be
differe
nitrog
ally,
quently
, iso
5-po1H sp
mainta
ation
usly. 1
rifica
D2 to
ne hy
nverte
etate
he 2
ed is
of st
ompa
9 e
nds in
nal enh
deuter
ease
n m
tion tim
ed to
less
ed by
for 17
ed re
d22
that,
at h
the
terat
tudie
igation
rivati
Tabl
ed,
prove
prot
ataly
this
e al
tic st
17-
lev
e ap
rent
rogen
, 2
ly sign
otopic
osition
spin
intainin
un
17 w
ation
o yield
hydra
rted i
e (S2H-la
isoto
stra
pared
exhib
the
nha
ratio
ed s
meth
time
o 19
less th
y the
7 ris
respo
2-cat
at, in
highe
e t
ted a
es on
ns w
ives
le 3.
with
ed lev
tons
lyst.
is cat
lone
tudy
-19
levels
pplie
stru
n c
ex
ignif
ic su
ions
in sys
ning
nder
was
ion an
ield
ate t
into
Sche
abell
opolo
rains
d to
bited
e pre
ance
on o
seve
hano
es in
9, b
han
e us
ing
onse
talys
in co
igher t
temp
analogues
on d
were
s of
. Po
ith deu
leve
s exh
Inte
talys
ne.
y of
Our
and
ed to
uctu
centr
xhibits
ifican
subst
s, as
stem
a 4
sim
syn
nd su
deu
then
oxa
eme
lled
logue
of M
pyr
d m
esenc
ment
of iso
veral-
nol-d4
in b
but th
tha
se of
to 3
ses, su
st (se
contras
temp
pera
gues
deut
e als
pyra
olariz
euter
els o
xhibiti
erest
st p
f S
r str
nd T1
to is
ural m
re
its
ntly
stitutio
s sh
ms t
JH-H
milar
nthe
subse
euter
en ga
xadia
3).[28
de
ue 1
M. tu
yrazin
much
nce
ents p
onia
-fold
. 18
both
he co
that se
of the
3.7%
such
see
ast to
pera
ature
gues of the
terat
lso co
yrazin
izatio
ratio
of po
iting
stingl
rove
SABRE
rate
1 rela
isonia
motif
and
mor
lowe
tion no
shown
that
H tra
r S
esise
seque
rated
ave
iazole28]
deriva
19 wh
tuber
nam
ch sho
of th
produ
azid
ld and
8 a
th m
corre
seen
e d22
%. H
ch tha
the
to 6,
ature
e cl
he IM
ated
cond
namid
tion le
tion a
olariz
6.4
gly,
ved to
RE
tegy
laxa
azid
tif to
nd su
re
er p
now
n in
exh
ansfe
SABR
ed fr
quent
ted is
2,5-
e 18
ative
which
ercu
mide
orter
the
duce
to g
and p
also
methano
resp
en with
22-IM
High
that 14
the sup
, the
es.
clea
IMes l
d an
nducted
ide (
levels
at the
izatio
and
the
to be
utili
for
xation
d-type
to tha
subst
rapid
polar
w resu
in 17
xhibit
er co
RE
from
pa
isonico
-d2-i
18 upo
e 1
h has
culosis
(1)
ter T1
SAB
ced b
give
pola
exh
thano
spond
ith
IMes
her te
4 yie
ppo
e op
The
arly
ligan
nalog
ed o
(1),
ls an
he 6-
ion,
d 7.7
e T1
e rem
utilising
incre
ion tim
pe s
at o
stitut
id re
rizat
sults
7, w
slow
coup
con
m dic
allad
icotina
ison
upon
18,
as s
is.[29
), the
T1 va
BRE
by SA
e 17
ariza
xhibit
ol-d4
ding
17.
liga
tem
ields
orting
ptim
Therefo
ch
nd.
ogue
on a
), the
nd r
-pos
esp
7%
1 va
mark
ing
reas
mes
subs
of 1,
tion
relax
tion
s fro
which
low re
pling
nditi
ichlor
ium
inate
niazi
n tre
was
show9] As
he un
alue
BRE ca
SABR
7, th
ation
ited
4 an
inc
. Th
igand,
mpera
s a 9
g in
mal e
ore
hang
es o
a ser
e res
elaxa
sition
specia
pola
value
kably
the
asing
by
strate
, with
in
xatio
leve
om 2
h act
elaxa
ng tha
itions
roiso
m cata
te 16
zid 17
eatm
s co
wn a
s sh
unlabe
s; b
cataly
RE a
these
n leve
sig
and
crease
hese
with
atur
9.7%
nform
exch
we
nges
of p
ries
esults
xatio
n (co
ially
lariza
es fo
ly cl
e is
the
isoto
tes.
ith it
the
tion
vels a2H la
cts to
xatio
that e
s to
onico
talyze
6. Re
17 tha
ment
compa
activ
shown
beled
betwe
lyst.
are lo
se rel
vels
gnifica
etha
se in
se va
th the
res a
% re
matio
hange
e no
the
pyra
of re
lts of
tion tim
comp
in e
ation
for 1
close
isonia
e SA
topic
Iso
con
e 4
than
are
label
to cre
n (ca
enab
tho
otin
zed
React
that co
t with
pared
ivity
wn in
d co
tween
Fur
low.
laxatio
of
cantl
thanol
n po
values
the po
also
eturn
tion).
ge ra
note th
e le
azina
relat
whic
times
pound
ethan
n w
12
se to th
iazid
ABR
c lab
oniazi
ntain
4-po
an 1
ach
lling
create
ca. 3
bles
ose
tinic ac
redu
ction
could
ith tr
ed
aga
n Tab
comp
n 4
rther
. Howe
xation
1.9‒2.1% ntly
l-d6
olariz
s ca
olariz
o res
n at
. Th
ate
that
leve
amid
ed 2
ich ar
s we
nd 12
anol-
with th
in th
that
d-ty
RE 1
belli
zid
ning
ositio
1 an
chieve
g at the
te tw
34.3
s 2.0
us
acid
eductio
n w
ld a
trieth
to
ainst
able
poun
and
rmo
oweve
n tim
‒2.1% longe
whe
izatio
can
izati
esult
313
hus w
for
wh
vels
ide2H-
are
ere
12)
-d6,
the
the
t of
ype1H-
lling
(2)
g a
ion.
and
ed.
the
two
3 s)
0%
sed
15
ion
with
also
thyl
its
st a
le 4,
nds
d 7
ore,
ver,
mes
‒2.1% ger
hen
ion
be
ion
lt in
3 K
we
17
hile
of
F
hyp
tre
inve
Se
ag
wer
de
pr
8,
re
6.6
wor
th
Tab
deri
Com
2
17
18
19
2
17
18
19
*[Ir
FULL
yper
end
invest
eekin
gent
ere
etect
repa
, 4 a
eturn
.6 an
orse
that is
able
derivati
ompound
17
18
19
17
18
19
*[IrCl(C
LL
erpola
wa
stigate
ing
ts W
to
ctabil
pared
and
ns o
and
se whe
is als
4.
tives
pound
(COD)(
ULL PAP
lariza
as
ated
impro
We h
be
ility
d thre
6 a
of 9.
1.8%
hen
lso s
T1
d
OD)(d22
PAPER
ation
not
indiv
prov
hypo
em
of o
ree s
and
.2, 1
% in
mix
seen
valu
-Ime
PER
n ach
t ob
dividu
vem
othe
emplo
one
sam
13
11.9
in th
ixed
en.
ues
Site
o-Hm-H
o-Hm-H
o-Hm-H
o-Hm-H
o-Hm-H
o-Hm-H
o-Hm-H
o-Hm-H
es)] u
R
chie
obse
ually
ment
esize
loyed
at
mples,
and
.9 and
the m
and
and
te
H:H:
H:H:
H:H:
H:H:
H:H:
H:H:
H:H:
H:H:
used
eved
rved
y to se
t, SA
ed th
d, it
the
s, co
d 14
and 2.
mixtu
nd ag
hype
T1(n
cat.)
7.47.5
34.434.3
9.540.7
7.99.2
5.24.9
24.526.2
12.134.7
5.06.2
as th
d us
d a
secu
ABR
that
mig
exp
contai
4. W
.5%
ture
agree
perpo
(no
(s)
Methanol
7.47.5
34.434.3
9.540.7
7.99.2
Ethanol
5.24.9
24.526.2
12.134.7
5.06.2
the ca
using
and
cure
RE st
if a
ight
xpense
tainin
While
% resp
and
es w
rpolariz
T1
ethanol
16.519.7
thanol
12.914.0
atalys
ing SA
ea
an o
studi
mix
be
nse o
ining e
e 6
spec
d he
with
zation
1(with ca
nol-d4
4.5.
16.5 (19.7 (
1924
6.6.
ol-d6
4.4.
12.9 (14.0 (
1418
4.5.
st
ABR
ach
optim
udies
xture
e po
of th
equim
and
ctive
henc
the
n lev
cat.) (s
4
.9
.8
(17.5(21.0
9.34.3
.4
.7
.4
.4
(15.5(17.4
4.38.0
.6
.0
RE i
ag
timal
s on
e of
ossib
the o
imola
nd 8
ely th
ce bo
fall
evels
s)
5)*0)*
5)*4)*
in th
agent
resp
n mix
two
ible
other
ar am
produ
this
both
ll in
of de
Pol
2.11.9
1.0
these
ne
spon
ixtur
o of th
to
er. W
mou
duce
cha
agen
rela
deuter
olarizati
1.20.5
2.1 ± 0.1.9 ± 0.
0.0.
0.0.
0.0.
1.07
1.38
0.880.9
0.50.
e sy
needs
onse.
res
these
imp
We
ounts
ced i
anged
ents
axatio
uterated
ation
1.2 ±0.5 ±
0.1 (3.70.1 (3.7
0.35 ±0.39 ±
0.37 ±0.11 ±
0.69 ±0.06 ±
± 0.090.08
8 ± 0.0.05
0.88 ±0.93 ±
0.51 ±0.06 ±
yste
s to
of t
se a
prove
there
s of
indiv
ed to
s pe
ion
ed is
n Leve
± 0.02± 0.09
(3.7 ±(3.7 ±
± 0.0± 0.0
± 0.0± 0.0
± 0.0± 0.0
09 (108)*.1 (1.05)*
± 0.0± 0.0
± 0.0± 0.0
ems
o b
thes
agen
e th
refo
6 an
ividu
o 6.
erfor
time
sonia
el (%)
29
± 0.3± 0.4
0404
0201
0701
1.82 ±
.41 ±
0708
0101
a
be
se
nts
he
ore
nd
idual
.4,
rm
es
azid
%)
3)*4)*
±
±
r
r
th
4
a
su
e
p
e
d
a
va
S
C
W
su
a
a
d
d
im
a
si
co
e
tim
a
a
h
is
fa4J
e
rem
resp
the
4.1%
as a
sugge
enh
pola
exam
disco
1.2%
asso
valu
Schem
Co
We
subst
and
a co
deute
dram
impro
a deu
signa
cond
effect
times
agen
availab
hyper
isoto
facilita
JH-H
enab
Fo
mains
spons
pola
% al
a co
gest
nhanc
arizati
mine
cove
% th
ociate
lue for
eme
onc
hav
stra
nd ison
cons
terati
matica
oved
deuter
al ga
dition
ct wh
s as
nt 6
able
erpola
topolo
tates
cou
bling
or the
s co
se le
lariza
lone
onse
sts th
cemen
ation
ined
vered
that
ated
for 13
3. Synthesis
clus
ave
ates
oniazi
sequ
ation
cally
ed re
terated
gains
ons a
hich
s hig
, th
e to
lariz
ogue
s re
uplin
ng effi
the
onsta
levels
ation
e to
sequ
that
ent
ion b
a s
d tha
of
inc
3 in
Synth
lusion
und
pyra
iazid (
uenc
of th
y im
relaxa
d SAB
ins of
at 9
h is
igh a
hereb
o th
ization
e du
relaxa
ng to
icac
mix
ant
ls an
ion lev
2.0%
uenc
it
prod
by
sam
at w
13
increas
acc
hesis
ions
ndertak
razina
(2) a
ce,
hese
impro
ation
ABR
up
9.4 T
ach
as 1
by
he
ion
ue t
ation
o th
cious
ixture
but
nd the
vel o
% an
ce wh
may
duce
this
mple
hile
incr
ses
ccordan
Synthesis of deuter
take
nam
and
we
se tub
oved
n tim
RE p
to 63
T re
chieve
145
leng
dete
tran
to re
n wi
the m
s po
e of
ther
the a
of 13
and
while
y be
ced w
is co
of
the
crease
in th
dance
deuter
ken a
mide
a se
ha
tubercu
d S
times.
pola
6300
esult
ved in
s w
ngthen
tectio
ansfer
remo
ithin
meta
polariz
4
ere is
asso
13 and
5.5%
e tha
e pos
with
comb
8 a
e po
sed
the T
ce w
deuterated
a sy
(1),
series
ave
culo
SAB
s. Fur
arizati
00 tim
lt to
in a
were
ening
ion
r ste
oval
in 3,
tal hy
izatio
and
is a si
ociate
and 1
5% in
that o
possi
the
bina
and
polariz
to
T1 va
ith th
ated isoniazid
syste
, me
s of
show
losis
BRE
rther
ation
times
to yie
a ma
e se
ng the
of
tep.
l of
whil
ydrid
tion tr
d 6,
sign
ted
14 bo
in the
of 1
sible
e su
ation
13
izatio
1.7%
value
these
isoniazid
ema
ethyl
the
own
drug
E res
er re
n tran
s tho
eld 20
atter
seen
the o
an
. 6
the
ilst a
ides wh
trans
, the
ignifica
rela
both
e m
14 s
ible to
ubstra
n s
3 as
ion o
% f
lues o
se ch
azid
atic
yl py
eir de
n tha
rug sc
respo
refine
ansfe
hose
20.3
er of
in m
obse
n M
re
e stro
also
whe
sfer.
e H
ant f
axatio
imp
mixtu
sees
im
rate
strate
s a
of 8
from
of ag
hang
anal
SAB
yrazin
eute
at t
caffo
onse
emen
er c
e see
3%
f se
met
erva
MR
repres
rong
o ma
en b
r.
H-5 po
fall in
tion tim
prove
re. T
s litt
prove
s th
tegy.
furthe
fell
m 0.9
gent
nges.
analogues
ABRE
zine-2
terate
the
ffolds
e a
nt th
cataly
en u
net
cond
thano
vation
resp
esents
g 3J
ainta
bound
pola
in th
time
e, fr
The
ittle
ve the
hat e
y. W
ther
ll to
.9%.
8 a
s.
ues
E st
2-ca
ted ana
sele
s resu
and
through
lyst,
under
po
ds.
nol-d
n win
pons
ts th
JH-H
taining
nd to
lariza
the o
es. In
from
T1
cha
the
exhib
We
r co
from
. Th
and fa
stud
carbo
analo
lectiv
sults
sig
ugh th
, resu
er B
olariz
T1
d4 so
indo
se
the
coup
ng a
to th
ation
other
In co
0.9%
of 1
ange
lev
bit w
the
contro
m 2.5
here
falls
udy o
oxyla
logue
ive
ts in
gnifi
the
sults
Boltz
zatio
rela
solutio
dow t
afte
op
upling
an effi
he ca
n of
er thr
contra
% and
13 fa
e. T
els
weak
erefo
ol a
.5%
e wer
s in th
of th
late
ues.
part
both
ifican
use
lts in
ltzma
tion,
laxatio
tion
that
fter th
ptimu
ng th
fficie
cataly
f 4
ree
ast,
and
alls
This
of
ker
ore
and
% to
ere
the
the
(3)
As
rtial
h a
ntly
e of1H
ann
an
ion
for
t is
the
um
hat
ient
lyst
,
F
re
enh
bio
th
inte
sy
pyra
insi
to
m
re
situ
pr
ca
age
a
pr
re
po
th
co
to
red
ga
clin
wil
eith
SA
exe
co
E
Po
we
Yo
[IrCl
eth
of
10
ra
sp
Sy
pro
inf
A
Th
092
Un
use
FULL
elaxa
nhan
iolog
the de
intensi
system
yrazi
insigh
to op
molecu
etain
tuatio
roce
cataly
gents
ser
rese
espo
olariz
the po
contin
to the
educe
ains
inica
ill be
ither
ABR
xem
contrib
Expe
Polari
were
Young
rCl(COD)
hano
par
0 s i
apidly
spectr
Synthe
roced
form
Ack
his w
9250
niver
sefu
LL
For
ation
ancem
gica
etect
sity
matic
zine-
ht in
ptimiz
cule
ning
tion
ceed
lyst.[15
ts ar
ries
sented
onse
By
izati
poten
tinuou
e po
ced
s and
ally
be po
er wo
RE ca
mplifie
ibute
peri
ization
cond
g’s Ta
COD)
ol-d6
rahyd
in the
y tran
rosco
hetic
dures
mation
know
work
506 a
ersity
ful disc
ULL PAP
For the
ion o
men
ally a
ction
rec
tic
-2-ca
nto t
ize
es fo
a 1H
in a
into15] I
re a
of
d da
e of w
ex
ion lev
ntial
us p
oint
in
nd
relev
poss
orkin
cata
ied
e po
iment
on tr
nducted
Tap.
)(NH
6 (0.6
ydrogen
he speci
ransport
copy.
c Proc
es and
on.
nowled
rk wa
and
y of
iscus
PAPER
e tub
of up
nts f
ame
ion of
ceive
stud
arbo
the d
the
or SA
H lab
acco
o this
In view
also
mix
ata
wea
xten
leve
ial for
proc
of
wat
relax
levan
sible
ing a
alyst
here
ositiv
ental
transfer
ed i
Sample
HC)]
6 mL)
rogen at
specif
sported
Procedu
and charac
ledgem
as s
098
York
ssion
PER
bercu
p to
from
enab
a 1H
ved und
dy
oxam
desi
det
ABR
abel
corda
is site
view
com
ixtur
that
weakly
nding
vels o
r the
ocess
inject
ter
axatio
nt in
to
at hig
sts in
e.[14b
tively
al S
nsfer
in a
mple
and
mL). Th
at a
ied f
d into
edur
haract
gem
suppo
98335)
rk. W
ns.
R
culosi
to 3
m SA
ble so
H sig
under
of
mide
sired
tectio
RE h
at th
dance
te vi
of th
mmo
res
at it
pola
g th
of th
their in
ss,[30]
ction
(see
tion
inform
imp
igher
in co14b, 14c
ly to t
Sec
proc
5 m
es we
d 20
The sa
press
fring
o the
res
cteri
men
porte
5), th
We
sis d
340%
ABR
solv
gna
er B
a
es, and
d deu
ion
hyper
the 5
e wit
via a
he fa
on, w
of
may
arisin
the
he ke
in vi
the
n, an
e su
rate
matio
prove
r pre
conju14c, 23]
the tr
ctio
procedu
mm
were
0 mM
amp
ssure
ge fie
e ma
and
izatio
nts
ed by
the M
also
drug
% a
RE of
lvent
nal that
Boltz
ser
and
euter
of th
erpo
5-H
ith th
a large
act
we a
thes
y be
ing sy
rela
key T
vivo
e pol
and
supp
tes
tion to
ve on
essu
junctio] We
trea
on
dure:
NM
prep
M o
ples we
e of
eld o
agne
nd c
on da
s
by Th
MRC
o than
ug pyra
and
of up
eth
at ha
tzma
ries
and iso
rium
these
polariz
or 1
the
ge J
that
also
ese
e po
syst
laxa
TB d
dete
lariz
thu
pportin
shou
to b
on th
sures
tion
e hop
atme
: The
NMR tu
pare
of su
were
3 ba
of an
et for
char
ata ca
he We
RC, Br
ank
razi
inc
p to 3
hano
as g
ann
of
oniaz
m su
se p
ization
1-H
fact
JH-H
t tan
test
age
ossible
tems
ation
drug
tection
izatio
us, d
ng
ould
be c
hese
s of
with
hope
ent o
The po
ube
ared as
substr
ere degass
bar. S
an NMR
r sub
haracter
can
Wellc
Bruke
k Pro
inam
creas
360
ol-d6
grea
dete
f p
zid s
ubstit
pharmac
ion.
site
ct th
cou
ndem
sted
ents
ible
ms un
ion t
gs s
ion.
ion lev
desp
info
d giv
colle
e res
p-H
h th
e tha
of tu
polariz
that
as fol
rate
gassed
Sam
MR spec
subsequent
cterizat
be found
llcom
er B
rofess
mide
ses
60% we
6, whi
ater tha
tectio
pyraz
subs
titutio
armac
In th
tes pr
at S
upling
m trea
the
. It
to
nder
times
show
As
level
spite
forma
ive
cted
spons
H2 or
the 2
at u
tubercu
zatio
t wa
llows;
(1-1
ssed p
ples
spect
quent
zation
ound
me T
iosp
ssor V
e (1)
in
were
which
than
on co
zine
bstrate
tion p
aceutic
he ca
rodu
SAB
ng in
eatm
effe
is
furth
r such
es a
own he
s SA
l can
the
ation
enou
ed. W
nses
or util2H-la
ultim
culo
n tra
was eq
ws; a
19)
prior
wer
ctrom
t inte
on: Fu
d in t
Trust
pin U
V. H
), incr
ave
e ach
ch co
n 25
cond
e-2-c
tes
patte
utica
case
duce
BRE
in the
tmen
ffect o
cle
ther
ch co
and
here
ABR
n be
e T1
n), th
nough
We p
s st
tilisin
abell
mately
losis.
ansfe
quip
5 m
in me
to th
re th
meter
errog
Full
the s
st (G
UK a
H. Pe
crea
verage
chieve
corre
2500 tim
nditio
carb
reve
tterns
ally im
e of
the
tran
the ass
nts w
of SA
ear fr
imp
cond
nd in
we
RE ca
e m
tim
these
gh sc
pred
still fu
ing a
lling
ly th
s.
er exp
pped
mM so
meth
he in
hen sh
r bef
gatio
exp
supp
Grants
and
Perry
ases
ge s
ved
espo
time
ions.
boxy
eals
s req
imp
f 1 a
e opt
ransfe
ssoc
with
SABRE
from
prov
dition
incre
e op
can
maintai
mes
se s
scop
dict t
furth
altern
ing stra
his w
experime
with
solut
hanol
ntroduc
shaken
efore
on by
experime
upplemen
ts
the
y for
s in
sign
in th
ond
es th
Th
ylate
ls cle
quire
portan
and
timu
er w
ciate
thes
BRE o
m th
ve th
ns.
easin
pen u
n be
intaine
being
sign
pe f
that
rther b
rnativ
rateg
wou
periment
h a
ution
nol-d4
roducti
haken f
ore bei
by NMR
eriment
ementary
r
T1
ignal
he
to
he
This
es,
lear
ed
ant
3,
um
will
ed
se
on
he
he
ing
up
a
ed
ing
ignal
for
t it
by
ive
gy
uld
ents
J.
of
or
ion
for
being
MR
ental
ary
K
C
S
4
[1[2
[3[4
[5
[6
[7
[8
[9
[1
[1
[1
[1
[1
Keyw
Cata
Supp
42c9
1]2]
3]4]
5]
6]
7]
8]
9]
10]
11]
12]
13]
14]
word
talysis
pportin
c9-b8f0
ds:
s • Is
ting in
f0-8
WHS.Sa74H.A.20Y.AnA.BaDeL.To(a)9020(a)HaTh10(U(a)PinvaKova26Ksh20LavieChZaCaY.ZhKu65Ch53K.P.J.SpC.10(a)CoKh32EllC.1378(a)CoR.SoJ.DeHigLew
Hyp
Isoto
infor
885a
WHO,Kus
Safir, V.4, 36
H. H. FoZum
013,Zha
AntimiBan
BalasuDelisle
Liu,Tonge
) A. Vi0-96;008,) J. H.
HanssThanin00, 1
(USA)) L. Scnes,
an deKonter,an de69; (c
Kshirs007,avie,
Chem.Zandt,Cance
YenZhangKurhan5-69;
Chen,33-54
HarrisWeNatt
SpectroC. R. Bo09, 5) R.
CowleKhaza23, 1liott,
C. Wh336889-80) M.
CockeR. KersSoc. 2
Burnear,
Hightoewis,
perp
opes
rma
a552
O, WHOshneV. K.
617-3Fox,mla,12,
ang,icrobnerjeubrae, W, Y. Xue, J.Viale; (b)252H. Ardson,ng, K.1015
200Schrö, Scien Brar, P.er Kl(c) Mrsaga
129, G. S.. So
t, M.er Ren, J.g, J.newic; (g), R. Bo44; (hrris,
Weitekatterer,troscBowe
5541W. Ad
wley, P.al, J.1708, S. B.
Whitwo8; (c)00.J. Co
ett, S.rsseb2011rns, A.S. B.
ton, A., R.
polar
s
ation
2bafa
HO Per, HK. Sm3621
x, ScieP. N388-M. M
b. Chee, E
bramanW. R.
Xu, CMede, SS. B, 2278
ArdenL. H
K. G58-101609, 106röde
cienceBrand. Haulink,
M. E.ar, C.
, 1294S. P
oc. 20LercheseaWoTrop
ewicz,J. S
Bok,(h) EL. S
ekampr, J.
sc. 199wers,
-5542.Adam
P. I. PJ. Lóp
-1711;B. Dood,
c) R. E
CowlS. B.baum
1, 133A. CB. DuA. J.E. M
rizatio
n via
afa0
PressH. Damith,1.
cienceNahid-404M. WhemE. DunianJaco
C. Sd. Ch
S. AimB. Du278-2nkjæ
HanssGolma0163106,er, Tce 20dt, Kutle,ConMerr. R.
2942-Payne
008,rche,archlber,pp, SR. E
S. Nek, R. HE. Y.S. Bap, J.
Barg97,
rs, D. P42.ms,P. Elpez-S11; (b
DuckeJ. AE. M
ley,. Duckm, D
33, 6CharltuckeJ. H
Mewi
tion
: DO
ss: Galalian,
h, J. H
ce 19id, S4.Wade
emotheubna
n, K.cobs,Sheahemme,
Ducke2291
kjær-Lassonan,3; (b5453. J. L
006,K. Uf, W.nceprritt,Mal-12943e, M, 130, R. P2006
r, A.S. NE. HelsonHurd. CheatcheAm.
rgon31, 293P. W
J. AElliott
Serr(b) K
kett, GAm. CMewi
R. WckettD. Ki6134rlton,ett, GHoopis, A
• SA
OI: 1
Genean, J.H. W
952,S. T.
e, Aer. 2au, AS. U
s, Sca, J.m 201
Curett, N1.arse
n, M.Proc.
(b) R.53-54Low314
ffmaT. W
pts MC. H
lloy,943;
M. O.30, 45Pehrso06, 6P. C
NelsoHurd,
n, Drd, Aekmelde. Ch
n, Pro293-
Weite
A. Agt, S.rranoK. D.G. GCheis, M
W. At, G.ilgou-613
, S. CG. Rper, MA. D.
SABR
10.1
eva,J. L.
Willia
, 116Cole
A. Sco2003A. QUm,cienceS. F10, 53rr. ON. J.
en, B. H. Lc. Na. R. R454.
wery,314, 44
ann,WenckMagnHarrA. D
; (d). Lea598-
hrson66, 1Chen
son, D, Ma
D. Vigppl.
kmeneer, P.hem.og. N-315ekam
guilaB. D
o, D.. Atkin
G. R.em. SMagn
Adam. G.
our, R37; (bCoom
R. GeM. K. Rob
RE •
1512
201. Sanams,
6, 12le, Na
Scorpi3, 52Quem
T. Wice 19Fowle53, 2
Opin.. Wo
B. FrLerc
Natal.Rizi,., C.46-44F. Ku
nckebn. R
rrisonD. ShC. Gabach,-459n, J.1085n, MD. B.agn.gnero. Magev, JP. Bh. SocNuc5.mp,
ar, KDuck
D. C. Wikinso
R. GreSoc.n. R
ms, K.R. Gr
R. E.(b) L
ombeGenov
Khanberts
• Tu
24/5
16.njurj, J. Am
29-1Nat. Re
io, H.2, 79mardWilso994,
wler, J2882. Cheood,
Fridlunrche,. Aca, Pro
Hilty,49; (b
Kurdbach
Reson, Z.
SherryGabe, T. R.99; (e. H. Ar55-1
M. J. AlB. Vig
Resron,gn.
J. HöBhatta
c. 20cl. Ma
J. Am
K. D.kett,Willion, M
Green,. 200
Reson
K. D.Gree
E. MeL. S.es, Mv, G.n, I.
rts, A.
ubercu
/5e44a
o, FAm.
134.Rev.
H. Zha90-79rd, V.son, D
, 263J. M.2-28em., Coo
nd, AR. S
cad. Sroc. N
y, D.(b) Azesa
ch, R.son. 200
Kovarry, J.ellieR. E(e) KArde
10860Albe
gneroson.J. KReso
övenacharya008,agn.
m. C
Atki, G. GiamsoM. J., J. Ló09, 1n. C
. Atkien, J.ewis,
LloydM. J.. G. RG. K. J. R
culo
4a9c
F. L.Che
v. Dru
hang795..D. C
63, 22. Ho
2891.Biol
oord.
A. GServiSci.Nata
. E. WA. Coau, S
R. Gru2007vacsJ. Ameri, SEykynK. Goenkja
860; (f)ers, Ron, J.Med
Kurhason. 2ner, Vrya,, 130. Re
Chem
kinsoG. Rson,
J. CoLópe131,
Chem
kinsoJ. A.
s, J. Aoyd, AJ. Cow
R. GKhazaRud
osis
c2-c9
Bachem. S
rug D
g, Z.
Collins,27-2
ooke
l. 201Chem
Gramrvin, M
(USal. Aca
WemommS. Jaruette, 31
cs, P.m. ChS. Ren, J.olma
kjaer-L) S.R. BJ.d. 200anew2008V. AB. D
0, 421eson.
m. S
son, MR. Gr, Scieowley,ez-S, 133
m. 201
son, M. B. LAm.A. Asgwley,
Greezal, Rddlesd
•
c968
ach, SSoc.
Disco
. Sun
ns, G230.
ker, P.
010,em.
m, G.M.SA) 2cad.
mmementannier, J.
1B, 2
hemeyno
J. Aman, RLarseJ. K
Bok,
2007,wicz
08, 34A. NoD. R
4212-.
Soc.
M. J.reen
ciencey, P.
Serra13362-
2015,
M. CLohmChesghay, G.en, LR. J.
esden
-
S. R.oc. 195
cov.
n, J.
G.
. J.
14,Rev.
.
2003. Sci.
er, At, B.in, J.J. J.255-
m. Soc.olds,m.R. i.
rsen,Kohler,
V.
, 58,cz, A.34,ortonRoss
4213.
198
J.n, I. Gce 20. I. Pano,
, 53,
C. R.man,em.ar, M. J.
L. A.J.n, Ca
R.52,
.
v.
3,i.
A.B.J. A.
Soc., A.
t.
er,
,A.
n,s, D.13.
87,
G.009,P., A.
,
R.n,
M.
A. R.
Cat.
A.
D.
,
F
[15
[16
[17
[18
[19
FULL
15]
16]
17]
18]
19]
LLULL PAP
SciWeJ. MM. TeComN. EsFeiteRes(a) A.IvanW.G. G.PraR. KaTheWa(a) R.ShiCheT. ThWaChe(c)W.CheD. A.WaSocF. P.J. 2M. JL. A.D. C.369CowleRay141L. A.CheSko250P. NikEur.(a)126ProM.63,RevNorcAng
PAPER
i. TeeerdeM. MTessmmuEshuitersson.A. Nnov,AdaG. R.
ravdivKapteeis, MarrenR. V.i, K.ekmTheiaddeekmM. LWadekmA. Ba
arrenc. 20P. C2016J. CA. RC. Wi9; (gwleyyner,16-1A. Rem.ovpin09.Nikor. J.M. Ca
6, 62roc. N
H. L, Volviewsrcottgew
PER
echnenbu
M. Smssari,un. 2uis,
rs, F.. 201
N. Prav, J. Pams,R. Grevtsev,
ptein,M. Tn, J.V. Sh
W. Wkmene
is, Mell, F
kmeneL. Truddel
kmeneBarskiy,n, B.016,
Colell6, 22
CowleR. HigWillia
(g) R.y, S.r, D.
1424R. Hig
B 20n, I.
kolaou201
Carr6228-NatalLevittl. 63
ws, Pt, P.
w. Ch
R
nol. 2urg,mits,, M.2013R. ARutj16, 26ravdiPhys.
s, S. Breenv, A, ChTruoMag
hcheWad
ev, J.M. L.F. Shev, J.ruonll, F.
ev, J.kiy, R. M., 138l, W.2, 1077ey, Sghtoamso. E. M. B. D. C. W4; (h)ghto015V. K
u, B.15, 2rravet
6229;al. Aca
evitt, in(Ed
Palo. J. Rhem.
2014S. G
s, R.C. F
13, 49Aspejes,265,ivtses. ChB. Dn, J.. V.
hemPng, Agn. Repin,ddel
J. Ph. Truhi, B.J. Amng, T. Shi
J. PhR. VGoo8, 80. S.
0777S. B
on, Dson, MMewDuckWilli) M.
on, R, 119Kopt
. M.21, 3
vetta,29; (bcad.Ann
ds.: MAlto
Rayn. Int.
4, 4,Glogde GFeite9, 73ers,S. S, 59-
sev, AChemDuck
J. CheYurkoPhysA. MReso, M.ll, Whys.
ruong. M.
m. ChT. Thi, B.
hys.V. Shodso080-Warr
7-10781B. DuD. KilMag
wis, Rckett,iamsoJ. B
R. E.19, 502tyug
Goo3156M. H
(b) GSci.
nualM. Ao, 201
yner,. Ed.
354ggler,Gelders,
7388-B. J.
S. W-66.A. V.
m. Bckett,
em.rkovsysCheM. Coson. 2
L. TW. S.
Cheg, A.
GooChemheis,. M. GChehche
son, E-808rren,781;
uckeilgougn. RR. A, G.son,Burns,. Mew
5020-g, Ch
odso6-316H. Le
G. Pilci. (US
l RevieA. Jo012,G. G. 201
44-35r, N.der, S.B. Bl-739
J. A.Wijme
V. Yu201R. A.Physkayem 2
Coffey2014
TruonWa
em. LM. Co
Goodsom. So, A.Goo
em. Cepin,E. Y.83; (en, S.1; (f)ett, G.ur, LResoA. Gre
G. R., J. Phs, P.
ewis,-502
Chem.
on, E.66.evittleio,
(USA)viewohns, pp.G. R.16, 5
554;N. Esh
S. ApBlum90.van
enga
Yurkov15, 1A. Gys. 2ya, H.2013y, E4, 24ng, T.rrenLett.Coffon, W.
Soc. 2M. Co
odsoC 20, A.
Y. Che(e) A
J. MR. E.
G. GL. S.on. Ch
GreenR. GPhys
P. J. Ra, S. B.27; (i). Co
E. Y
tt, J. Am, M. Ca201
w of Phson,
89-R. Gr
55, 1
; (c)shuis,Appe
umich,
n Wea, M.
vska119,reen
2009H. M3, 14
E. Y.248, 2
T. Tn, B.. 2015fey,W. S2015Coffe
dson, W015,M. Cekm. W.
MalcoE. Me. R.Lloyd
Chemn, M.Greenys. Ch
RaynB. D(i) V.omm
. Ch
Am.Carr
10, 107PhysT. J.105reen15642
B. J.s, A.elt, S, F. R
eerde. Tess
kaya,136
n, D.9, 13
M. Vie14, 33
Che23-26
Theis,M. G
15, 6R. V
S. Wa5, 13ey, R
W. S119
Coffey,kmenev,
. J. LcolmsoMewis,
Greyd, J.m. 20. C. Rn, Rhem
yner,Ducke. V. Z
mun.
hekm
. Cherrave107,ysicaJ. Ma; (d)
n, S.42-1
J. A.H. J.
S. S.Rutje
rdenbussari
H.-M19-1. C. W
131; (c)eth,327-ekme26.s, A.Good6, 196V. Sharre
37, 140R. V
S. Wa9, 8786ey, Tev, J.Loganson,s, K.
reen,J. A.2014R. C
R. O.m. B 2r, G. G
ckett,Zhivo2015
kmene
em.etta,17135
cal Chartine) S. SB. D
15645
. vanJ. En. Wymes, C
urg,ri, J.
M. V1362Willi
(c) A.K. L.-333enev,
. M.odson961-hcheen, E1404V. Sharren786-8T. TheJ. Aman, T, Che. D. AR. AB. L, 52
CockJoh
2015G. RJ. P
vonit15, 51
ev, C
Soc.M. H
135-1heminez),S. RDuck45; (e
nEngwe
WymenChe
, M. C.. Ma
Vieth29; (bliams
A. N.L. Ivan31; (dv, W.
Coffon, E.-196epinE. Y.4-140
Shchen, E.8797
TheisAm. Ch
T. Them.Atkin
A. GrLohm, 35
kett,hn, P.5, 1R. GrPhystko,
51, 2
Chem
c. 20H. L1713istry
), AnnRoy,kett,(e) T.
werdanga,
em.
C.agn.
th, K.(b) R.son,
Ivanov(d) T
W. S.
ffey,E. Y.67; (bn, K.
Y.07;
epin,E. Y.
7; (ds, W.ChemTheis
Eur.tkinsonGreen
man58-
M. JP. J.
119,Green
.I. V.
2506
m.
004,Levitt39; (c
try, VonualP.
,T.
a,,
L.R.,
v,T.
S.
F.Y.
b)W.
, K.
(d)W. S.m.s, J.r.n,n,n,
J..
n,
V.-
,tt,(c)
Voll
[2
[2
[2
[2
[2
[2
[2
[2
[2
[2
[3
20]
21]
22]
23]
24]
25]
26]
27]
28]
29]
30]
ThW.Q.P.FeB.E3S.DuH.M.G.ReD.Ko18(a)ChF.Gre19ChAgR.S.A.A.44(a)ReReM.ChG.DuGoFe(a)DuR.ElveS.R.LeElve56
Theis,W. P.Q. Wa
J. RaFekete
DucE3188
S. RoDuckeH. Zen
. TybG. G. R.ResonD. A. BaKovtun8, 89) K.
ChemGye
Grego995,
ChungAgentsR. E. M
B. DuJ. HoC. Wh
4, 10) N.
Rev. 1Reson
. GaChemiG. NavDuarteGonzáFernán
) J.-B.DuckeR. Gre
verfeKne
R. E. Meibfritz,verfe
670-5
, G. X.Huh
Wang,Raynte, G.ckett8-E3Roy,ett, Anng, JburnR. Gr
n. 20Barsnov,
9-93.E. Be199
enesor, R.38,
g, H.ts ChMewisDuckHolmWhitwo
077-1Bloe
1948n. Sp
Gangapistryvarre
rte-Faález-ndezB. Ho
ett, R.een,
rfeldt,echt,Mewis
fritz, Jrfeldt,
5677
X. Ohn, VW. S
yner, M. G.t, Pro
3194y, P. NAngeJ. Xu
rn, J. AGree013,
rskiy,ov, I. V
.Bergm96, 39s, C.. Ra3902. Sayahemowis, Mckett,mes,twoo1083emb8, 73pectropura
ry 200ete-V
ajard-Salaz, Bi
HoveR. E.
D. L, Nat, T. B
wis, GJ. G., J.-B7.
Ortiz,V. BluS. WM. J.R. G
roc..Norcoew. Cu, J.A. B
en, S237A. N
V. Ko
man39, 3. A. Sapolu02-39yahiotheM. F, CheP. J.
od, S3.
berge3, 67rosc
ram, K09, 4Vázq
rdo, J.azar,
Biorg.vener,
. MewLeibft. CoBäuG. G. KorviB. Hö
z, A. Wum,
WarreJ. BuGreeNata
rcott,ChemGille
B. LoS. B.7, 73N. Poptyu
ann, M3394Sharpu, G.907;i, W.er. 2007Feketem.J. RaS. B.
en, E79-712;
sc. 20K. K46, 30
zquez,J. Var, E.. Me
r, N. Sewis,fritz,omm
äumlisbG. R.rvink,
Höven
W. J.S. J.
en, Surns,en, Lal. A
, P. J.m. 2en, M
ohmaDuck
3-78.Pravdyug, P
M. H4-340rpe,. Lucia; (c). R. Ja007,te, GCom
ayne. Duck
E. M12; (b
010,K. Re309-z, G
argasHern
ed. CSchw
s, L. Az, J. Gm. 20sberg. Grek, J.ner,
J. LoJ. MaSci.
s, A.L. A.Acad
J. Ra2016M. T
man, Rckett.divtsePhys
H. Cyn00; (b, K. E
ucianS. CJaco, 51,G. G
ommuer, Mucket
M. Pu(b) G56,
edda-316
G. M.s-VilrnánChem
chwadA. RG. K013,ger,
reen,HenJ. P
oganMalco
AdvM. Ola
A. R.d. Sc
Rayne6, 12T. MR. E.tt, P.
tsev,s. C
Cynam(b) ME. Beno, JC. Ngobs,, 243
G. R.un. 2
M. J.tt, Da
PurceG. Pi217
a, Jo6.. a. Mllarre
ndezm. 2derla
R. HigKorvi, 4, 2A. L
, M.nnigPhys
n, K.olmsv. 20OlaruHigh
Sci. (USA
er, G.28, 1
McMaE. Me
P. C.
K. LChem
mon,M. H.
BergmJ. T.
Ngo, O., J. T.30-2. Gre2015. Cowle
Dalto
ell, R.Pileio7-231ourn
Molirreal,z-Nú2007
rlapp,Highto
ink,2946L. CreBurn
g, G.s. Ch
. E. Cson, E016,ru, Phton
(USA)
G. G1587ahonewis,M. va
L. Ivam. Che
, J. TH. CynmannWelO. ZT. W2435
reen,5, 51wley,
on Tra
R. V.o, Pro1.
rnal of
na-SS. E
úñez,, 15,T. L
on, SJ. H6-29reme
rns, PPütz,
hem
ClaytE. Y2.
P. Non, R.) 20
G. R.5871-15
n, D.s, K.van Z
vanov,hem
T. Wynamnn, Hlch,
ZimhWelch
435.A. C
51, 98y, G.ransa
Pourog. N
f He
SalinEstra, S., 550
LickeS. M.Henn
2946;er, SP. J.z, D
m. B 2
ytor,Y. Ch
orcotE. M17,
Gre5874. ArteD. A
Zijl,
v, K.m. Ph
Welchmon,H. J.
J. Mhony,
ch, Ant
C. W857-9. G. Rsactio
und,Nucl.
etero
nas,rada-
Said02-55ert, S. Kenn
nig, D(b)
S. B.J. RaynD. vo2016
Y. Fhekm
tt, MMew114
reen,874.
emoAtkinJ. M
. V.hys.
ch, J., R.Han
Med.y, W.ntim
Whitw9859R. Gons
Physcl. Ma
rocycli
Z. VSotod-5508S. B.nny,D. voP. R. Duyner,
von6, 12
Fengkmenev,
M.wis, S,
S. B
ov, JkinsonMagn
201
J. MeGim
n, L.. Che. J.
micro
wood9.
Gree2015
ys.Magn.
clic
V.o, F.
8..
y, G.vonRoveucketr, D.
20,
g,nev,
S.
B.
J.-n,n.
16,
ed.Gimi,
. B.em
rob.
d,
en,15,
n.
F.
G.
edo,ett,D.
,
F
F
Th
py
der
hyp
Th
ca
m
bee
to
FULL
FUL
he t
yrazi
eriva
yper
hrough
cataly
minute
een
to in vi
LL
LL
ube
zina
ative
erpola
ugh
lysts
tes a
ach
vivo
ULL PAP
L P
ercul
amide,
es h
larize2H-l
T1 li
and
hieve
ass
PAPER
PAP
ulos
de, i
have
ed u
labe
lifetim
~20
ed w
sess
PER
PE
sis d
ison
ve been
using
belling
imes
20% p
whic
ssme
R
ER
drug
niazi
een o
g SA
g the
s of
pola
ich op
ent.
gs,
zid a
optim
ABR
the dr
ove
ariza
opens
and t
timally
RE.
rugs
ver two
ation
s the
their
y
s and
two
n ha
the doo
ir
d
ave
oor
Phil
G.
Pag
Ach
Hyp
Life
Dru
ilip No
R. G
ge No
hiev
perp
etim
ug S
Norco
Gree
No.
ving
pola
imes
Scaf
cott,
een, S
– P
g Hig
lariza
in a
affold
, Pe
Sim
Page
igh 1
rization
a Ra
ds
Peter J
imon
ge No.
1H N
on Lev
ange
J. R
B. D
o.
Nuc
Leve
e of
Rayn
Duck
lear
vels w
f Tu
yner,
ckett*
ar
with
uberc
Gar
*
h Lo
erculo
ry
ong
losiss